Institutional members access full text with Ovid®

Share this article on:

Emergency department use of neuromuscular blocking agents in children


Special Features: CME Review Article

From the Division of Emergency Medicine (*Attending Physician), Children’s Hospital of The King’s Daughters, Norfolk, Virginia; and Pediatric Critical Care Medicine (Division Director), Pediatric Transport Medicine (Medical Director), Children’s Hospital of The King’s Daughters, Norfolk, Virginia, and Pediatrics (Associate Professor), Pediatrics Eastern Virginia Medical School, Norfolk, Virginia.

EDITORS’ NOTE: This article is the fourth of four that will be published in 2000 for which a total of up to 4 Category 1 CME credits can be earned. Instructions for how credits can be earned appear on the last page of the Table of Contents.

The authors have disclosed no significant financial or other relationship with any commerical entity pertaining to this educational activity.

Address for reprints: Kathleen A. Doobinin, MD, Division of Pediatric Emergency Medicine, Children’s Hospital of The King’s Daughters, 601 Children’s Lane, Norfolk, Virginia 23507; e-mail:

© 2000 Lippincott Williams & Wilkins, Inc.